Gastrointestinal
Thiopurines (azathioprine, mercaptopurine)
Immunosuppressive purine antimetabolites that stop lymphocytes proliferating; steroid-sparing maintenance treatment in Crohn disease and ulcerative colitis.
Mechanism of action
- Azathioprine is converted to 6-mercaptopurine, then to thioguanine nucleotides.
- These block purine synthesis and are built into DNA, so dividing lymphocytes cannot proliferate.
- Their full effect takes several months.
- Thiopurine methyltransferase (TPMT) inactivates mercaptopurine; people who inherit low TPMT activity build up toxic levels.
Molecular targets
- Purine synthesis in lymphocytes: Inhibited by thioguanine nucleotides
Drugs in Thiopurines (azathioprine, mercaptopurine)
- Azathioprine (Prodrug of mercaptopurine.)
- Mercaptopurine (6-MP)
Therapeutic uses
- Maintaining remission in Crohn disease and ulcerative colitis, allowing steroids to be withdrawn
- Preventing transplant rejection and treating autoimmune diseases
Diseases it treats
Adverse effects
- Bone marrow suppression
- Pancreatitis
- Hepatotoxicity
- Infections
- A small rise in lymphoma and skin cancer
Contraindications by condition
- Absent TPMT activity (Contraindicated): Thioguanine nucleotides accumulate: severe, life-threatening marrow suppression.
- Acute pancreatitis (Use with care): They can cause pancreatitis.
- Liver cirrhosis (Use with care): They can damage the liver.
Other cautions and interactions
- Allopurinol inhibits xanthine oxidase, which also clears mercaptopurine: toxic levels unless the dose is greatly reduced.
Written from
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 36, Immunosuppressants, Antimetabolites
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 40, Gastrointestinal and Antiemetic Drugs, Drugs used to treat inflammatory bowel disease
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 55, Immunopharmacology, Azathioprine
Educational reference. Not medical advice, diagnosis or treatment.